Apr 29, 2020
Vanda Pharmaceuticals to Announce First Quarter 2020 Financial Results on May 6, 2020
Apr 15, 2020
Vanda Pharmaceuticals Announces Initiation of "CALYPSO" to Study the Role of Genetic Variation in COVID-19 Infections in Collaboration With University of Washington Medicine
Apr 08, 2020
Vanda Pharmaceuticals Inc. And The University of Illinois at Chicago Announce Partnership To Identify Novel Antivirals Against COVID-19
Feb 25, 2020
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
Feb 18, 2020
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020
Nov 06, 2019
Vanda Pharmaceuticals Reports Third Quarter 2019 Financial Results
Oct 23, 2019
Vanda Announces New Study Results Showing a High Degree of Inbreeding in Beagle Dogs
Aug 21, 2019
Vanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketing Officer
Jul 22, 2019
Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder
Jul 22, 2019
Vanda Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019
Jun 18, 2019
Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
May 31, 2019
Vanda Pharmaceuticals Announces Participation at the Jefferies 2019 Global Healthcare Conference
May 22, 2019
Tradipitant in the Treatment of Gastroparesis: Vanda Presents Clinical Trial Results at DDW 2019
May 01, 2019
Vanda Pharmaceuticals Reports First Quarter 2019 Financial Results
Apr 18, 2019
Vanda Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019
Feb 05, 2019
Vanda Pharmaceuticals Takes a Stand Against Unnecessary Animal Research
Nov 08, 2018
Vanda Pharmaceuticals Announces Participation at November 2018 Investor Conferences
Sep 26, 2018
Vanda Pharmaceuticals Announces Participation at Oppenheimer and Cantor Fitzgerald Fall 2018 Investor Conferences
Sep 20, 2018
Vanda Announces Listing of a New HETLIOZ® Patent in the FDA Orange Book
Sep 04, 2018
Vanda Pharmaceuticals Announces Participation at September 2018 Investor Conferences